norcotinine has been researched along with Acute Confusional Senile Dementia in 1 studies
norcotinine: RN given refers to compound without isomeric designation; metabolite of cotinine
| Excerpt | Relevance | Reference |
|---|---|---|
| "The currently available therapies for Alzheimer's disease (AD) and related forms of dementia are limited by modest efficacy, adverse side effects, and the fact that they do not prevent the relentless progression of the illness." | 1.40 | Evaluation of nicotine and cotinine analogs as potential neuroprotective agents for Alzheimer's disease. ( Adam, BL; Gao, J; Terry, AV, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, J | 1 |
| Adam, BL | 1 |
| Terry, AV | 1 |
1 other study available for norcotinine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Evaluation of nicotine and cotinine analogs as potential neuroprotective agents for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Survival; Cells, Cultured; Cotinine; Humans; | 2014 |